These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17336500)

  • 1. Remission criteria for schizophrenia: evaluation in a large naturalistic cohort.
    De Hert M; van Winkel R; Wampers M; Kane J; van Os J; Peuskens J
    Schizophr Res; 2007 May; 92(1-3):68-73. PubMed ID: 17336500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of schizoaffective disorder. Are there any differences with respect to schizophrenia?
    Pinna F; Sanna L; Perra V; Pisu Randaccio R; Diana E; Carpiniello B;
    Riv Psichiatr; 2014; 49(1):41-9. PubMed ID: 24572583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptom remission in first episode patients.
    Addington J; Addington D
    Schizophr Res; 2008 Dec; 106(2-3):281-5. PubMed ID: 18926666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
    Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
    Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission in schizophrenia: analysis in a naturalistic setting.
    Eberhard J; Levander S; Lindström E
    Compr Psychiatry; 2009; 50(3):200-8. PubMed ID: 19374962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission in schizophrenia: Results from a 1-year study of long-acting risperidone injection.
    Lasser RA; Bossie CA; Gharabawi GM; Kane JM
    Schizophr Res; 2005 Sep; 77(2-3):215-27. PubMed ID: 15908183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
    Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
    J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
    J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between symptomatic remission and functional outcome in first-episode schizophrenia.
    Bodén R; Sundström J; Lindström E; Lindström L
    Schizophr Res; 2009 Feb; 107(2-3):232-7. PubMed ID: 18957275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
    Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
    J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-based and clinician-based support for the remission criteria in schizophrenia.
    Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
    Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
    Wobrock T; Köhler J; Klein P; Falkai P
    Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization.
    Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Kotowsky N; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2015 Aug; 166(1-3):69-79. PubMed ID: 26027848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
    Jäger M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Riedel M; Bottlender R; Strauss A; Möller HJ
    Pharmacopsychiatry; 2008 Sep; 41(5):190-5. PubMed ID: 18763221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders.
    Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Huff W; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Möller HJ; Riedel M
    Schizophr Res; 2009 Sep; 113(2-3):210-7. PubMed ID: 19560901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premorbid adjustment in schizophrenia and schizoaffective disorder.
    Saracco-Alvarez R; Rodríguez-Verdugo S; García-Anaya M; Fresán A
    Psychiatry Res; 2009 Feb; 165(3):234-40. PubMed ID: 19162333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
    Keefe RS; Frescka E; Apter SH; Davidson M; Macaluso JM; Hirschowitz J; Davis KL
    Am J Psychiatry; 1996 Jun; 153(6):806-11. PubMed ID: 8633694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, open-label study to evaluate symptomatic remission in schizophrenia with risperidone long-acting injectable in Korea.
    Lee NY; Kim SH; Cho SJ; Chung YC; Jung IK; Kim CY; Kim DH; Lee DG; Lee YH; Lim WJ; Na YS; Shin SE; Woo JM; Yoon JS; Yoon BH; Ahn YM; Kim YS
    Int Clin Psychopharmacol; 2014 Sep; 29(5):279-87. PubMed ID: 24583566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.